Stempoint Capital’s ADARx Pharmaceuticals ADRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.04M Buy
+52,000
New +$1.04M 0.19% 74

Other funds holding ADRX

Stempoint Capital's ADRX Position: Q3 2026 in Review

Stempoint Capital opened a new position in ADARx Pharmaceuticals (ADRX) in Q3 2026: 52,000 shares worth $1.04M. The stake represents 0.19% of the portfolio and ranks #74 among its holdings.

62 funds tracked by Wall St. Rank hold ADRX as of Q3 2026.

  • Stempoint Capital held 52,000 shares of ADARx Pharmaceuticals worth $1.04M as of Q3 2026.
  • ADARx Pharmaceuticals was a new Stempoint Capital position in Q3 2026.
  • ADARx Pharmaceuticals made up 0.19% of Stempoint Capital's portfolio in Q3 2026, its #74 holding.
  • 62 funds tracked by Wall St. Rank held ADARx Pharmaceuticals as of Q3 2026.

Based on Stempoint Capital's 13F filing for Q3 2026, filed 16 Nov 2026.